Status:
RECRUITING
The Trans-Led Care Study
Lead Sponsor:
Illinois Institute of Technology
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Substance Abuse
Substance Addiction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is testing a new mutual-help group called "the TLC program" for transgender adults who use substances or are recently in recovery. The TLC Program is based on Acceptance and Commitment Ther...
Detailed Description
Transgender (trans) populations are disproportionately impacted by HIV compared to the general population (nearly 1 in 7 trans women are living with HIV; 3.2% of trans men are living with HIV compared...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Eligible transgender adults must:
- be 18 years of age or older;
- speak primarily English;
- live in the U.S.;
- have a gender identity different from their assumed gender, or sex assigned, at birth;
- identify as a person of transgender experience;
- endorse having experienced two or more problem(s) related to alcohol or other drug use within the past 12 months.
Exclusion
Key Trial Info
Start Date :
February 10 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2027
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT06880705
Start Date
February 10 2025
End Date
July 31 2027
Last Update
March 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Illinois Institute of Technology
Chicago, Illinois, United States, 60616